glycopyrronium bromide


Also found in: Wikipedia.

glycopyrronium bromide

An ANTICHOLINERGIC drug used by anaesthetists to dry up secretions during general anaesthesia. Brand names are Robinul and Robinul neostigmine.
References in periodicals archive ?
Contract notice: Open house original discounts 2018-01 - glycopyrronium bromide / formoterol / beclomethasone (drug combination)
Clinical studies have shown that Glycopyrronium bromide significantly improves lung function and exercise endurance, as well as decreases the risk for exacerbation (flareups or lung attacks).
Tenders are invited for Inhaler Containing Glycopyrronium Bromide 50 Mcg Plus Indacateral 110 Mcg
A product of researchbased Swiss healthcare company Novartis, glycopyrronium bromide is a type of longacting bronchodilator, a drug that widens air passages of the lungs.
Glycopyrronium bromide was exclusively licensed to Novartis in April 2005 by Vectura and its co-development partner Sosei.
The FLIGHT 1 and 2 studies met their primary objectives with twice-daily QVA149 demonstrating statistically significant and clinically meaningful improvements in lung function (FEV1 AUC0-12) at Week 12, compared to indacaterol and glycopyrronium bromide in moderate-to-severe COPD patients.
Overall, Novartis presented 14 abstracts, including data from the investigational QVA149 (fixed-dose combination of indacaterol maleate / glycopyrronium bromide) IGNITE Phase III clinical trial program, the glycopyrronium bromide (SeebriA BreezhalerA) GLOW Phase III clinical trial program and the indacaterol maleate (OnbrezA BreezhalerA) INERGIZE Phase III/IV clinical trial program.
Novartis announced today that the fifth QVA149 (indacaterol maleate / glycopyrronium bromide) Phase III study, SPARK, met its primary endpoint of a reduced rate of moderate-to-severe COPD exacerbations compared to glycopyrronium bromide (Seebri Breezhaler).